PMAM
VRXA

Picton Mahoney Asset Management’s Veraxa Biotech AG VRXA Stock Holding History

Picton Mahoney Asset Management’s Portfolio VRXA Stock Details VRXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
+175,000
New +$1.4M ﹤0.01% 1056

Other funds holding VRXA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Picton Mahoney Asset Management's VRXA Position: Q2 2026 in Review

Picton Mahoney Asset Management opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 175,000 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #1056 among its holdings.

6 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

  • Picton Mahoney Asset Management held 175,000 shares of Veraxa Biotech AG worth $19.3K as of Q2 2026.
  • Veraxa Biotech AG was a new Picton Mahoney Asset Management position in Q2 2026.
  • Veraxa Biotech AG made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #1056 holding.
  • 6 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.